FDA Can’t Inspect Its Way Out Of Import Safety Problems – Schultz, Sharfstein
This article was originally published in The Gray Sheet
Executive Summary
Increasing the number of foreign device facility inspections alone will not dramatically improve FDA import safety, agency leaders say